Mon, 26 Jan 2015 14:00:00 GMT ~ PharmaCyte Biotech's Expanded Follow-up Study on Malignant Ascites Fluid Accumulation in Final Stages of Preparation
[GlobeNewswire] - SILVER SPRING, Md. -- PharmaCyte Biotech, Inc. (OTCQB:PMCB), a clinical stage biotechnology company focused on developing targeted treatments for cancer and diabetes using its signature live cell encapsulation ...
Thu, 15 Jan 2015 18:58:55 GMT ~ PharmaCyte Biotech’s Pancreatic Cancer Treatment Named as Near-Term Approach to Rising Pancreatic Cancer Rates
[at noodls] - Share SILVER SPRING, MD, January 15, 2014 (GLOBE NEWSWIRE) - PharmaCyte Biotech, Inc. (OTCQB: PMCB), a clinical stage biotechnology company focused on developing targeted treatments for cancer and diabetes ...
Thu, 15 Jan 2015 14:00:00 GMT ~ PharmaCyte Biotech's Pancreatic Cancer Treatment Named as Near-Term Approach to Rising Pancreatic Cancer Rates
[GlobeNewswire] - SILVER SPRING, Md. -- PharmaCyte Biotech, Inc. (OTCQB: PMCB), a clinical stage biotechnology company focused on developing targeted treatments for cancer and diabetes using its signature live cell encapsulation ...
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.